Inventor · disambiguated record
Lihua Shi
Also filed as: SHI LIHUA
4 granted patents·11 pending applications·0 citations·filing 2019–2023
52Inventor score
Files withBASF CORP4TAVOTEK BIOTHERAPEUTICS HONG KONG LTD4ZHEJIANG HUAKANG PHARMACEUTICAL CO LTD4QINGDAO HISENSE HITACHI AIR CONDITIONING SYS CO LTD2TAVOTEK BIOTECHNOLOGY JIANGSU CO LTD1
Top patents by PatentIndex Score
15 records- 0160US12392505B2Air conditionerQINGDAO HISENSE HITACHI AIR CONDITIONING SYS CO LTD·Filed 2023·Granted Aug 19, 2025·0 cites·18 claims
- 0260US2023240344A1Sweetener liquid for preventing and relieving intestinal sugar alcohol intolerance and preparation method and application thereofZHEJIANG HUAKANG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0359US2022071251A1Method for improving sensory attributes of sugar alcohol and application thereofZHEJIANG HUAKANG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0457US2024207830A1Scr catalyst comprising zeolitic material having aft framework structure and synthesis of the sameBASF CORP·Filed 2022·Application pending·0 cites
- 0553US2024174523A1Synthesis of zeolitic material having aft framework structure and scr catalysts comprising the sameBASF CORP·Filed 2022·Application pending·0 cites
- 0653US2024382938A1Synthesis of cha zeolitic materials, cha zeolitic materials obtainable therefrom and scr catalysts comprising the sameBASF CORP·Filed 2022·Application pending·0 cites
- 0748US12181163B2Air conditionerQINGDAO HISENSE HITACHI AIR CONDITIONING SYS CO LTD·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0848US2021379204A1Method for calculating tolerance dose of human body to sugar alcohol and functional sugarZHEJIANG HUAKANG PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0945US2022119549A1Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereofTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1045US2022153869A1Shielded and homing bispecific antibody that simultaneously inhibits angiogenic pathway targets and her2 family proteins and uses thereofTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 1143US12435131B2Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signalingTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2020·Granted Oct 7, 2025·0 cites·40 claims
- 1243US2022395009A1Enteral sustained-release sugar alcohol additive, preparation method therefor and application thereofZHEJIANG HUAKANG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1339US12486321B2Agents that interfere with IL-1BETA receptor signallingTAVOTEK BIOTECHNOLOGY JIANGSU CO LTD·Filed 2020·Granted Dec 2, 2025·0 cites·19 claims
- 1439US2021009674A1Bispecific antibodies to tnf-alpha and il-1beta and uses thereofTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 1537US2024116038A1Zeolitic material having a cha-like framework structure and synthesis of the sameBASF CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lihua Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →